BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/23/2016 9:07:00 AM | Browse: 313 | Download: 694
Publication Name World Journal of Pharmacology
Manuscript ID 22416
Country of Manuscript Source United Kingdom
2015-08-28 08:34
Peer-Review Started
2015-09-01 21:39
To Make the First Decision
2015-11-24 14:40
Return for Revision
2015-11-27 08:21
2015-12-11 06:17
Second Decision
2015-12-29 11:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-01-07 16:57
Articles in Press
2016-01-07 16:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-02-24 15:19
Publish the Manuscript Online
2016-03-04 15:35
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Non-selective beta-blockers in cirrhosis: Current concepts and controversies
Manuscript Source Invited Manuscript
All Author List Neil Rajoriya and Dhiraj Tripathi
Funding Agency and Grant Number
Correspondence To Dr. Dhiraj Tripathi, Consultant Hepa­tologist, Honorary Senior Lecturer, Department of Hepatology, the New Queen Elizabeth Hospital, Edgbaston, Queen Elizabeth Medical Centre, Birmingham B15 2TH, United Kingdom. dhiraj.tripathi@uhb.nhs.uk
Keywords Variceal haemorrhage; Non-selective beta-blockers; Portal hypertension; Liver cirrhosis
Core Tip This article serves to discuss the changing role of non-selective beta-blockers in liver disease and portal hypertension. For many years non-selective beta-blockers have been at the forefront in reducing portal hypertensive complications such as variceal haemorr-hage, however recent data has questioned their role in advanced liver disease. This article reviews their role in portal hypertension, discusses recent advances in the field and reviews the controversy recently generated regarding their role in advanced liver disease.
Publish Date 2016-03-04 15:35
Citation Rajoriya N, Tripathi D. Non-selective beta-blockers in cirrhosis: Current concepts and controversies. World J Pharmacol 2016; 5(1): 15-31
Url http://www.wjgnet.com/2220-3192/full/v5/i1/15.htm
DOI http://dx.doi.org/10.5497/wjp.v5.i1.15
Full Article (PDF) WJP-5-15.pdf
Full Article (Word) WJP-5-15.doc
Revised Manuscript 22416-Review.doc
Peer-review Report 22416-Peer-review(s).pdf
Answering Reviewers 22416-Answering reviewers.pdf
Scientific Misconduct Check 22416-Scientific misconduct check.pdf
Scientific Editor Work List 22416-Scientific editor work list.pdf
Audio Core Tip 22416-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 22416-Conflict-of-interest statement.pdf
Copyright License Agreement 22416-Copyright assignment.pdf